Clinical pharmacology of recombinant human luteinizing hormone: Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Fertility and Sterility

• Publication date

  1998-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0015-0282(97)00501-3PMID 9496327
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Standardization of symbols in clinical pharmacology

  2004cited by this paper
• Clinical pharmacology of recombinant human follicle-stimulating hormone (FSH). I. Comparative pharmacokinetics with urinary human FSH.

  1998cited by this paper
• Comprehensive Pharmacokinetics of Urinary Human Follicle Stimulating Hormone in Healthy Female Volunteers

  1995cited by this paper
• Pharmacokinetics of recombinant human luteinizing hormone after intravenous, intramuscular, and subcutaneous administration in monkeys and comparison with intravenous administration of pituitary human luteinizing hormone.

  1995cited by this paper
• Recombinant human luteinising hormone: an effective new gonadotropin preparation.

  1994cited by this paper
• Comparative pharmacokinetics of two urinary human follicle stimulating hormone preparations in healthy female and male volunteers.

  1993cited by this paper
• Comparing the glycosylation patterns of recombinant glycoproteins.

  1992cited by this paper
• Clinical-pharmacological studies on human menopausal gonadotrophin.

  1988cited by this paper
• Plasma clearance in the rat of the LH bioactivity of two human LH standards of differing molecular composition.

  1988cited by this paper
• The Physiology of reproduction

  1988cited by this paper
• Structure of human luteinizing hormone alpha subunit.

  1978cited by this paper
• Hormonal Proteins and Peptides

  1973cited by this paper
• Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man.

  1968cited by this paper
• EFFECTS OF HUMAN MENOPAUSAL GONADOTROPHIN PREPARATIONS IN DIFFERENT BIOASSAY METHODS.

  1964cited by this paper
• Assay of the follicle stimulating hormone based on the augmentation with human chorionic gonadotropin.

  1953cited by this paper

• Comparative Analysis of Commercial Immunoassays for the Determination of Total, Intact, and Nonintact Luteinizing Hormone in Urine

  2024cites this paper
• Luteinizing hormone supplementation in controlled ovarian stimulation: the Iran Delphi consensus

  2024cites this paper
• Urine Sampling Protocol Recommendations for Reliable Determination of Total Urinary Luteinizing Hormone Immunoreactivity in the Pediatric Population

  2023cites this paper
• Male infertility and gonadotropin treatment: What can we learn from real-world data?

  2022cites this paper
• Rooted in pre-assisted reproductive technology times menotropins are still used today: a narrative review of literature

  2021cites this paper
• Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus

  2021cites this paper
• A SIGLE INJECTION OF CORIFOLLITROPIN ALFA SUPPLEMENTED WITH hCG INCREASE FOLLICULAR RECRUITEMENT AND HIGH-QUALITY EMBRYOS IN THE RABBIT

  2021cites this paper
• A single injection of corifollitropin alfa supplemented with human chorionic gonadotropin increases follicular recruitment and transferable embryos in the rabbit

  2019cites this paper
• The Development of Gonadotropins for Clinical Use in the Treatment of Infertility

  2019cites this paper
• A Multicenter, Randomized, Equivalence Trial of a New Recombinant Human Chorionic Gonadotropin Preparation versus Ovitrelle® for Ovulation in Women Undergoing Intrauterine Insemination Following Ovarian Stimulation

  2019cites this paper
• Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment

  2018cites this paper
• Effect of mid-follicular phase recombinant LH versus urinary HCG supplementation in poor ovarian responders undergoing IVF - a prospective double-blinded randomized study.

  2017cites this paper
• Drugs used for ovarian stimulation: Clomiphene citrate, aromatase inhibitors, metformin, gonadotropins, gonadotropin-releasing hormone analogs, and recombinant gonadotropins

  2017cites this paper
• Pharmacokinetic, pharmacodynamic, and clinical aspects of ovulation induction agents: A review of the literature

  2017cites this paper
• A Computational Model of the Rainbow Trout Hypothalamus-Pituitary-Ovary-Liver Axis

  2016cites this paper
• Clinical Applications of Gonadotropins in the Male.

  2016cites this paper
• Роль ЛГ в овариальной стимуляции

  2016cites this paper
• Gonadotropin in Assisted Reproduction: An Evolution Perspective

  2015cites this paper
• Efficacy, efficiency and effectiveness of gonadotropin therapy for infertility treatment

  2015cites this paper
• Ovulation Induction in Hypogonadotropic Hypogonadism

  2015cites this paper
• The Role of LH in Controlled Ovarian Stimulation

  2015cites this paper
• Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech

  2014cites this paper
• A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology

  2014cites this paper
• Luteinizing hormone and human chorionic gonadotropin: origins of difference.

  2014cites this paper
• First evidence of ovulation induced by oral LH agonists in healthy female volunteers of reproductive age.

  2013cites this paper
• Outcome from consecutive ICSI cycles in patients treated with recombinant human LH and those supplemented with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH-agonist protocol

  2013cites this paper
• Déclencher l’ovulation

  2013cites this paper
• The role of LH in ovarian stimulation.

  2012cites this paper
• LH and hCG Action on the Same Receptor Results in Quantitatively and Qualitatively Different Intracellular Signalling

  2012cites this paper
• Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature.

  2012cites this paper
• The Use of rLH, HMG and hCG in Controlled Ovarian Stimulation for Assisted Reproductive Technologies

  2012cites this paper
• Lutropin Alfa

  2012cites this paper
• Who needs LH in ovarian stimulation?

  2011cites this paper
• Glycosylation of Therapeutic Proteins

  2010cites this paper
• Recombinant human follicular stimulating hormone and recombinant human luteinizing hormone in a 2:1 ratio combination. Pharmacological characteristics and clinical applications

  2010cites this paper
• Effects of recombinant human LH and hCG on serum and urine LH and androgens in men

  2009cites this paper
• Ovarian luteinizing hormone priming preceding follicle-stimulating hormone stimulation: clinical and endocrine effects in women with long-term hypogonadotropic hypogonadism.

  2009cites this paper
• Recombinant human FSH and recombinant human LH in a 2:1 ratio combination: a new tool for ovulation induction

  2009cites this paper
• Bioequivalence of recombinant human FSH and recombinant human LH in a fixed 2 : 1 combination: two phase I, randomised, crossover studies

  2008cites this paper
• Analysis of 100 Women with Infertility Due to Ovarian Dysfunction Who Succeeded in Delivering Live Children after Kampo Therapy Diagnosed by "Zheng"

  2008cites this paper
• Follicular development induced by recombinant luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in anovulatory women with LH and FSH deficiency: evidence of a threshold effect*

  2008cites this paper
• New insights into the evolution of chorionic gonadotrophin.

  2008cites this paper
• Gonadotropins in doping: pharmacological basis and detection of illicit use

  2008cites this paper
• Effect of Transient Hypothyroidism During Infancy on the Postnatal Ontogeny of Luteinising Hormone Release in the Agonadal Male Rhesus Monkey (Macaca mulatta): Implications for the Timing of Puberty in Higher Primates

  2008cites this paper
• Endocrine characteristics of ART cycles

  2008cites this paper
• Pharmacokinetic factors contribute to the inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome.

  2007cites this paper
• Outlook: who needs LH in ovarian stimulation?

  2006cites this paper
• Exploiting LH in ovarian stimulation.

  2006cites this paper
• The role of luteinizing hormone activity in controlled ovarian stimulation

  2005cites this paper
• Molecular pharmacology of gonadotropins

  2005cites this paper
• Papel de la Hormona Luteinizante en Pacientes Mayores de 34 años con Estimulación Folicular Múltiple para Fertilización In Vitro: Primeros Resultados

  2004cites this paper
• Comparison of recombinant human luteinising hormone (r-hLH) and human menopausal gonadotropin (hMG) in assisted reproductive technology

  2003cites this paper
• A pharmacokinetic and endocrine comparison of recombinant follicle-stimulating hormone and human menopausal gonadotrophin in polycystic ovary syndrome.

  2003cites this paper
• Treatment of female infertility with recombinant human luteinising hormone: is there a benefit over other available drugs?

  2003cites this paper
• Pregnancy after administration of high dose recombinant human LH alone to support final stages of follicular maturation in a woman with long-standing hypogonadotrophic hypogonadism.

  2003cites this paper
• Stimulation ovarienne: la LH exogne est-elle ncessaire chez toutes les patientes?

  2002cites this paper
• Hemodynamic changes induced by urinary human chorionic gonadotropin and recombinant luteinizing hormone used for inducing final follicular maturation and luteinization.

  2002cites this paper
• [Ovarian stimulation: is exogenous LH necessary in all patients?].

  2002cites this paper
• The use of LH activity to drive folliculogenesis: exploring uncharted territories in ovulation induction.

  2002cites this paper
• The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation.

  2002cites this paper
• The effect of gonadotrophins with differing LH/FSH ratios on the secretion of the various species of inhibin in women receiving IVF.

  2001cites this paper
• Clinical review 126: Roles and novel regimens of luteinizing hormone and follicle-stimulating hormone in ovulation induction.

  2001cites this paper
• Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study.

  2001cites this paper
• Recombinant Human Luteinizing Hormone Is as Effective as, But Safer Than, Urinary Human Chorionic Gonadotropin in Inducing Final Follicular Maturation and Ovulation in in Vitro Fertilization Procedures: Results of a Multicenter Double-Blind Study*

  2001cites this paper
• The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain.

  2001cites this paper
• Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.

  2000cites this paper
• The role of gonadotropins in follicular development and their use in ovulation induction protocols for assisted reproduction

  2000cites this paper
• Recent advances in clinical aspects of in vitro fertilisation.

  2000cites this paper
• Role of LH and FSH in ovarian function.

  2000cites this paper
• Recent advances in clinical aspects of in vitro fertilisation.

  2000cites this paper
• Biochemical and functional aspects of gonadotrophin-releasing hormone and gonadotrophins.

  2000cites this paper
• Disappearance of endogenous luteinizing hormone is prolonged in postmenopausal women.

  1999cites this paper
• A prospective, randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization.

  1999cites this paper
• Clinical pharmacology of recombinant human luteinizing hormone: Part II. Bioavailability of recombinant human luteinizing hormone assessed with an immunoassay and an in vitro bioassay.

  1998cites this paper
• Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone.

  1998cites this paper
• Time-course effects of human recombinant luteinizing hormone on porcine Leydig cell specific differentiated functions.

  1998cites this paper
• Reproductive Biology and Endocrinology Open Access the Role of Aromatase Inhibitors in Ameliorating Deleterious Effects of Ovarian Stimulation on Outcome of Infertility Treatment Part One

  year unknowncites this paper
• Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Dovepress Recombinant Follitropin Alfa/lutropin Alfa in Fertility Treatment

  year unknowncites this paper
• Reproductive Biology and Endocrinology Administration of Follitropin Alfa and Lutropin Alfa Combined in a Single Injection: a Feasibility Assessment

  year unknowncites this paper
• The LH role in ovarian stimulation

  year unknowncites this paper